Evidence map›Paper›PMID 37332344›Full record

ArticleFrontiers in pharmacology2023

Expert consensus on neurodevelopmental outcomes in pregnancy pharmacovigilance studies.

R L Bromley, M Bickle Graz, M Bluett-Duncan, C Chambers, P Damkier, K Dietrich, H Dolk, K Grant, S Mattson, K J Meador and 16 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

R L BromleyDivision of Neuroscience, Faculty of Medicine, School of Biological Sciences, Biology and Health, University of Manchester, Manchester, United Kingdom.
M Bickle GrazNeonatology, Department Woman-Mother-Child, Lausanne University Hospital, Lausanne, Switzerland.
M Bluett-DuncanDivision of Neuroscience, Faculty of Medicine, School of Biological Sciences, Biology and Health, University of Manchester, Manchester, United Kingdom.
C ChambersDivision of Environmental Science and Health, Department of Pediatrics, University of California San Diego School of Medicine, San Diego, CA, United States.
P DamkierDepartment of Clinical Pharmacology, Odense University Hospital, Denmark and Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
K DietrichDepartment of Environmental and Public Health Sciences, Division of Epidemiology, University of Cincinnati College of Medicine, Cincinnati, OH, United States.
H DolkMaternal, Fetal and Infant Research Unit, Faculty of Life and Health Sciences, Ulster University, Coleraine, United Kingdom.
K GrantDepartment of Environmental and Occupational Health Sciences, School of Public Health, University of Washington, Seattle, WA, United States.
S MattsonCenter for Behavioral Teratology, San Diego State University, San Diego, CA, United States.
K J MeadorDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Palo Alto, CA, United States.
H NordengPharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo, Oslo, Norway.
T F OberlanderDepartment Pediatrics and School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
A OrnoyHebrew University Hadassah Medical School, Adelson School of Medicine, Ariel University, Jerusalem, Israel.
A RevetINSERM University of Toulouse 3, Toulouse, France.
J RichardsonUK Teratology Information Service, Newcastle, United Kingdom.
J RovetDepartment of Psychology, University of Toronto, Toronto, ON, Canada.
L Schuler-FacciniGenetics Department, Hospital de Clinicas de Porto Alegre, Universidade Federal Do Rio Grande Do Sul, Porto Alegre, Brazil.
E SmearmanDepartment of Surgery, Emory University, Atlanta, GA, United States.
V SimmsSchool of Psychology, Faculty of Life and Health Sciences, Ulster University, Coleraine, United Kingdom.
C VorheesDepartment of Pediatrics, Division of Neurology, University of Cincinnati College of Medicine and Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
K WideDepartment of Pediatrics, CLINTEC, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
A WoodClinical Sciences, Murdoch Children's Research Institute, Melbourne, VIC, Australia.
L YatesNorthern Genetics Service, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, United Kingdom.
E YstromDepartment of Mental Disorders, Norwegian Institute of Public Health, Oslo, Norway.
T A SuprajaNational Institute of Mental Health and Neurosciences NIMHANS, Bangalore, Karnataka, India.
J AdamsDepartment of Psychology, University of Massachusetts Boston, Boston, MA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

in utero exposuremedicinesneurobehaviorneurodevelopmentpharmacovigilancepregnancyteratogens

Identifiers

PMID37332344
PMCPMC10270323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.